I see there are sweet FA comments on the S66 thread.
Keen to get people's views on what they are paying for Bio-E - i.e. is the multiple reasonable against forecasted EBITDA? Are they overpaying or is this appropriate?
No one concerned with the amount of dilution we're going to see on the back of this?
I see there are sweet FA comments on the S66 thread.Keen to get...
Add S66 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 78296 | 1 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| S66 (ASX) Chart |
Day chart unavailable